FDA: Pancreatic enzyme drugmakers must submit NDA
Certain pancreatic drugs could be withdrawn from market unless their manufacturers go through NDA process
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Recent Videos
Related Content
